Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.79 USD | +0.72% | +36.10% | -16.96% |
May. 02 | Poseida Therapeutics to Receive Up to $600 Million in Cancer Gene Therapy Research, Development Deal With Xyphos | MT |
May. 01 | Malin Corp investee signs agreement with Astellas Pharma | AN |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Equities
- PSTX Stock
- Revisions Poseida Therapeutics, Inc.